Pennsylvania

Pennsylvania has solidified its status as a premier global life sciences hub, powered by a sophisticated ecosystem that spans from "bench to bedside."

The Commonwealth is best known as the "Cellicon Valley," a nickname earned through Greater Philadelphia's undisputed leadership in cell and gene therapy and pioneering mRNA technology.

This innovation is anchored by world-class academic research institutions, including the University of Pennsylvania and University of Pittsburgh, which consistently rank among the top in the nation for NIH funding and academic R&D expenditures.

The state's pharmaceutical manufacturing sector is currently seeing historic growth, highlighted by multi-billion dollar investments from industry giants like Eli Lilly and Johnson & Johnson in next-generation biologics and injectable medicines.

Beyond traditional pharma, Pennsylvania's medical device sector thrives in clusters like the Lehigh Valley, where global leaders in medtech leverage advanced manufacturing and robotics.

Pittsburgh has emerged as a powerhouse for healthcare innovation, specifically where artificial intelligence (AI) intersects with drug discovery and digital health.

With over 3,000 life sciences companies and a workforce of more than 100,000, the state offers an unmatched infrastructure for clinical trials and commercialization.

From the breakthrough CAR-T cell therapies developed at Penn Medicine to the cutting-edge radioisotope production in Philadelphia, Pennsylvania remains at the forefront of solving the world's most complex medical challenges.